Regulus Therapeutics Inc. (NASDAQ: RGLS)
$1.78
+0.0400 ( +2.30% ) 532.2K
Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. The product candidate of the company is RGLS8429, an anti-miR next-generation oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease (ADPKD), and is in Phase 1b clinical development.
Market Data
Open
$1.78
Previous close
$1.74
Volume
532.2K
Market cap
$116.53M
Day range
$1.70 - $1.81
52 week range
$1.08 - $3.79
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Aug 14, 2023 |
10-q | Quarterly Reports | 53 | Aug 08, 2023 |
8-k | 8K-related | 14 | Aug 08, 2023 |